This analysis further identifies association of EBV seropositivity with immune dysregulation characterized by biomarkers of hyperinflammation (increased CRP, ferritin, and MAS), immune depression (decreased whole blood ex vivo TNF response to endotoxin), and thrombotic microangiopathy (decreased ADAMTS 13 activity). The gene discussed is CRP; the disease is thrombotic microangiopathy.